Athens, OH, United States of America

Jennifer V Hines

This inventor holds 2 USPTO granted patents. Top assignee: Ohio University. Active years: 2006-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer V Hines. Retrieved from https://idiyas.com/inventor/jennifer-v-hines

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jennifer V Hines

Introduction

Jennifer V Hines is an accomplished inventor based in Athens, OH (US). She has made significant contributions to the field of RNA research, holding 2 patents that focus on innovative compositions and assays for RNA binding.

Latest Patents

Her latest patents include "Compositions that bind antiterminator RNA and assay for screening for such compositions" and "Compounds that are selective binding agents specific for RNA secondary and tertiary structures and a fluorescence assay for detecting the binding of small molecules to T-box antiterminator model mRNAs." These patents feature novel tri-substituted oxazolidinones and amino alcohols. The assays provide fluorescently labeled model mRNAs that include conserved sequence information typical of antiterminator bulge regions found in the mRNA of T-box gene regulatory systems.

Career Highlights

Jennifer is affiliated with Ohio University, where she continues her research and development in RNA binding technologies. Her work has the potential to advance understanding in gene regulatory systems and therapeutic applications.

Collaborations

Some of her notable coworkers include Frank J Grundy and Stephen Bergmeier, who contribute to her research endeavors.

Conclusion

Jennifer V Hines exemplifies innovation in the field of RNA research through her patents and collaborations. Her work is paving the way for future advancements in molecular biology and therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…